12935 Results

People

  1. Weigelt
    Weigelt
  2. Reis-Filho
    Reis-Filho
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Berger
    Berger
  6. Deasy
    Deasy
  7. Solit
    Solit
  8. Lewis
    Lewis
  9. Schultz
    Schultz
  10. De Stanchina
    De Stanchina

Groups

  1. Sloan Kettering Institute Postdocs (12935)
  2. GSK Faculty (6209)
  3. Department of Medicine (4655)
  4. Sloan Kettering Institute Faculty (3489)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)
  7. Department of Pathology and Laboratory Medicine (2500)
  8. Center for Hematologic Malignancies (2323)
  9. Epidemiology and Biostatistics (1996)
  10. Human Oncology and Pathogenesis Program (1984)
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3611)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12935)
  2. GSK Faculty (6209)
  3. Department of Medicine (4655)
  4. Sloan Kettering Institute Faculty (3489)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (393)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12935)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic relevance of CD4+ T-cells in the microenvironment of newly diagnosed follicular lymphoma (FL) patients is independent of the tumor gene expression profile
    Meeting Abstract

    Mondello, P.; Fama, A.; Larson, M. C.; Feldman, A. L.; Yang, Z. Z. J.; Villasboas, J. C.; Huet, S.; Tesson, B.; Slager, S. L.; Link, B. K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Effects of electroacupuncture and auricular acupuncture for chronic pain in cancer survivors: The PEACE randomized controlled trial
    Meeting Abstract

    Mao, J. J.; Liou, K.; Panageas, K.; Baser, R. E.; Romero, S. A. D.; Li, Q. S.; Xiao, H.; Bao, T.; Kantoff, P. W.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • DREAMM-2: Single-agent belantamab mafodotin (GSK2857916) in patients with relapsed/refractory multiple myeloma (RRMM) and renal impairment
    Meeting Abstract

    Lee, H. C.; Cohen, A. D.; Chari, A.; Hultcrantz, M.; Nooka, A. K.; Callander, N. S.; Suvannasankha, A.; Badros, A.; Libby, E. N.; Trudel, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Immediate post-thermal ablation biopsy of colorectal liver metastases to predict oncologic outcomes
    Meeting Abstract

    Vasiniotis Kamarinos, N.; Vakiani, E.; Gonen, M.; Kemeny, N. E.; Covey, A. M.; Brown, K. T.; Brody, L. A.; Deipolyi, A. R.; Camacho, J.; Boas, F. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Immune infiltration and angiogenesis as markers of outcome in the post-nephrectomy setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT)
    Meeting Abstract

    Hakimi, A. A.; Voss, M. H.; Kuo, F.; Silagy, A. W.; Marker, M.; Reising, A.; Millholland, J.; Chan, T. A. T.; Russo, P.; Motzer, R. J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Alternative anti-CD20 antibody versus desensitization for lymphoma patients with drug hypersensitivity reactions requiring discontinuation of rituximab, obinutuzumab, or ofatumumab
    Meeting Abstract

    Ghione, P.; Joffe, E.; De Paola, N.; Mainardi, T.; Noor, S. J.; Bobillo, S.; Myskowski, P. L.; Palomba, M. L.; Moskowitz, A. J.; Mato, A. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial
    Meeting Abstract

    Garcia-Aguilar, J.; Patil, S.; Kim, J. K.; Yuval, J. B.; Thompson, H.; Verheij, F.; Lee, M.; Saltz, L. B.; on behalf of the OPRA Consortium
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prospective agnostic germline testing in pediatric cancer patients
    Meeting Abstract

    Fiala, E.; Kennedy, J.; Kemel, Y.; Mauguen, A.; Mandelker, D.; Zehir, A.; Birsoy, O.; Bouvier, N.; Maio, A.; Latham, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PET-directed chemoradiation (CRT) with induction FOLFOX compared to induction carboplatin/paclitaxel (CP) in patients with locally advanced esophageal adenocarcinoma (EA)
    Meeting Abstract

    Carr, R.; Hsu, M.; Tan, K. S.; Bains, M. S.; Bott, M.; Ilson, D. H.; Isbell, J. M.; Janjigian, Y. Y.; Maron, S. B.; Park, B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The utility of blood-based molecular tools-the NETest-to monitor and evaluate the efficacy of PRRT in neuroendocrine tumors
    Meeting Abstract

    Bodei, L.; Kidd, M. S.; Singh, A.; Drozdov, I. A.; Malczewska, A.; Baum, R. P.; Krenning, E.; Modlin, I. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save